I started the Summa Consulting Group after gaining over 20 years of biopharma experience from organizations such as Promontory Therapeutics, Janssen Research and Development, BIND Therapeutics, and Momenta Pharmaceuticals (acquired by Johnson & Johnson). As a member of senior leadership teams, I was responsible for the strategic clinical development and execution of oncology, drug delivery, infectious disease, cardiovascular and neurology assets.
At Promontory Therapeutics, I was assigned the newly created role of VP of Clinical Development, progressing their lead asset, PT-112, into clinical studies. A major portion of my late-state development came from Janssen Research & Development, where I was a Director of Clinical Science in the oncology therapeutic area. During his tenure there, I was a leader of a clinical program for ZEJULA® (niraparib), which received an FDA breakthrough designation in 2019.
Before Janssen, I was a leading member at BIND Therapeutics as Senior Director of Clinical Operations and Clinical Science. While there, I was responsible for all aspects of clinical design, execution, and analysis. At BIND, I had a major role in submitting the company’s first Investigational New Drug (IND) Application. Previously, I held positions of increasing responsibility in chemistry, manufacturing, and control (CMC), non-clinical, and program management roles.
I graduated with a B.S. from the Pennsylvania State University in Chemistry and an M.B.A from Boston University. I also hold a PMP certification from Boston University.
“Jason is an extremely bright, hard-working, and talented individual. He is a pleasure to work with, and his experience, insight, and knowledge of clinical research continue to amaze me. Jason gives his all and brings team members together for a common goal. He would be an asset to any company.“
— Jane
“From Day 1, Jason hit the ground running and was immediately impactful to our programs. He asks thoughtful questions in meetings, regularly updates his project deliverables, and delivers quality work on time. Jason consistently exceeded expectations despite being asked to juggle significant responsibilities associated with multiple projects. Plus, he is a pleasure to work with.”
— Melissa
“Jason is a natural, low-key leader with great skills at both the strategic and operational levels. Over our years together, he expanded upon his core skill set in CMC and formulations to lead project team regulatory submissions and clinical operations. Jason has developed a wide range of experience in understanding the important aspects of the various functions of clinical-stage programs and provides excellent leadership to help teams collaboratively achieve their goals and milestones.”
— Jeff
“I had the pleasure of working with Jason in one of my first forays into small biotech. His knowledge and insight into clinical research were integral to our team’s success. Jason was always willing to share what he knew and assist the team in finding answers outside of his remit. His ability to see multiple sides left all team members feeling that their concerns were understood and recognized. Jason can see the big picture while keeping track of the details and driving timelines. His expertise, integrity, and ability to facilitate clear communication would make him an asset to any team.”
— Sharon
“Jason is an accomplished clinical scientist. He is highly collaborative and a creative problem solver. He is very respected by international key opinion leaders and fosters these relationships to help further the company’s research goals.”
— Randy
